The overexpression of reactive oxygen and nitrogen species (RONS) is closely associated with the onset and progression of diverse chronic diseases, such as cancer, Alzheimer's disease, and chronic diabetic ulcers. Hydrogen therapy, as an emerging and promising general-purpose therapeutic approach, normally utilizes molecular H2 to selectively eliminate RONS and maintain intracellular redox homeostasis, thereby treating related chronic diseases.
